Over the past 3 decades, advances in the molecular genetics of thyroid cancer (TC) have
been translated into diagnostic tests, prognostic markers, and therapeutic agents. The main …

Objective Advances in our understanding of the molecular biology of thyroid tumours is
being rapidly translated into their clinical management. This review summarizes the current …

Thyroid nodules are quite common, and the determination of a nodule of concern is
complex, involving serum testing, radiology and, in some cases, pathological evaluation. For …

Thyroid nodules are common, and the accurate diagnosis of cancer or benign disease is
important for the effective clinical management of patients. Molecular markers are a helpful …

Molecular diagnostic testing has had a profound impact on the diagnosis and management
of thyroid nodules and thyroid cancer. Based on the tremendous expansion of knowledge of …

Routine morphologic cytology is the basis for any kind of (integrated) molecular FNA
diagnostics. The rule out (gene expression classifier) approach requires confirmation by …

Objective To describe the molecular markers thus far evaluated for use in the care of
patients with clinically relevant thyroid nodules. Methods We review the currently available …

In recent years there has been an increased awareness of the genetic alterations underlying
both benign and malignant neoplasms of the thyroid. Next-generation sequencing (NGS) is …

Background The role of commonly associated genetic mutations in thyroid cancer is being
actively investigated. However, the role of genetic alterations in tumorigenesis, the …

Thyroid cancer is the most common endocrine malignancy with an estimated 43,800 new
cases to be diagnosed in 2022 and representing the 7th most common cancer in women …